Your browser doesn't support javascript.
loading
Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer.
Kong, Yifan; Zhang, Yanquan; Mao, Fengyi; Zhang, Zhuangzhuang; Li, Zhiguo; Wang, Ruixin; Liu, Jinghui; Liu, Xiaoqi.
Affiliation
  • Kong Y; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
  • Zhang Y; Department of Animal Sciences, Purdue University, West Lafayette, Indiana.
  • Mao F; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
  • Zhang Z; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
  • Li Z; Department of Animal Sciences, Purdue University, West Lafayette, Indiana.
  • Wang R; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
  • Liu J; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
  • Liu X; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
Mol Cancer Ther ; 19(12): 2490-2501, 2020 12.
Article in En | MEDLINE | ID: mdl-33024029
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Enhancer of Zeste Homolog 2 Protein / Metformin / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Enhancer of Zeste Homolog 2 Protein / Metformin / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2020 Document type: Article Country of publication: